ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Prognostic value of tumor‑infiltrating lymphocytes in estrogen receptor‑positive and human epidermal growth factor receptor 2‑negative breast cancer
Molecular and Clinical Oncology
◽
10.3892/mco.2021.2414
◽
2021
◽
Vol 15
(6)
◽
Author(s):
Chikako Honda
◽
Sasagu Kurozumi
◽
Ayaka Katayama
◽
Bishoy Hanna‑Khalil
◽
Kei Masuda
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Prognostic Value
◽
Growth Factor Receptor
◽
Tumor Infiltrating Lymphocytes
◽
Estrogen Receptor Positive
◽
Epidermal Growth
◽
Infiltrating Lymphocytes
Download Full-text
Related Documents
Cited By
References
Prognostic value of Ki67 and p53 in patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: Validation of the cut-off value of the Ki67 labeling index as a predictive factor
Molecular and Clinical Oncology
◽
10.3892/mco.2016.776
◽
2016
◽
Vol 4
(4)
◽
pp. 648-654
◽
Cited By ~ 11
Author(s):
MASAHIRO OHARA
◽
KAZUO MATSUURA
◽
ETSUSHI AKIMOTO
◽
MIDORI NOMA
◽
MIHOKO DOI
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Epidermal Growth Factor
◽
Prognostic Value
◽
Growth Factor Receptor
◽
Ki67 Labeling Index
◽
Estrogen Receptor Positive
◽
Epidermal Growth
Download Full-text
Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor‑positive/human epidermal growth factor receptor type 2 negative breast cancer
Oncology Letters
◽
10.3892/ol.2018.9853
◽
2018
◽
Cited By ~ 2
Author(s):
Yuichiro Miyoshi
◽
Tadahiko Shien
◽
Akiko Ogiya
◽
Naoko Ishida
◽
Kieko Yamazaki
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Epidermal Growth Factor Receptor
◽
Growth Factor Receptor
◽
Tumor Infiltrating Lymphocytes
◽
Clinicopathological Factors
◽
Estrogen Receptor Positive
◽
Epidermal Growth
◽
Infiltrating Lymphocytes
Download Full-text
Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells
Molecular Medicine Reports
◽
10.3892/mmr.2018.8580
◽
2018
◽
Cited By ~ 1
Author(s):
Seung Taek Lim
◽
Ye Won Jeon
◽
Hongki Gwak
◽
Se Young Kim
◽
Young Jin Suh
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Breast Cancer Cells
◽
Growth Factor Receptor
◽
Anticancer Effects
◽
Estrogen Receptor Positive
◽
Epidermal Growth
◽
Positive Breast Cancer
Download Full-text
Abstract OT1-03-01: Phase 1/1b study of novel oral selective estrogen receptor degrader (SERD) LSZ102 in combination with alpelisib (BYL719) in estrogen receptor-positive (ER+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) with progression on endocrine therapy (ET)
10.1158/1538-7445.sabcs18-ot1-03-01
◽
2019
◽
Author(s):
G Curigliano
◽
S Cresta
◽
Y-S Yap
◽
D Juric
◽
FP Duhoux
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Epidermal Growth Factor
◽
Advanced Breast Cancer
◽
Phase 1
◽
Growth Factor Receptor
◽
Estrogen Receptor Positive
◽
Epidermal Growth
Download Full-text
Abstract PD7-07: Final analysis of phase 1 study of elacestrant (RAD1901), a novel selective estrogen receptor degrader (SERD), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer
10.1158/1538-7445.sabcs19-pd7-07
◽
2020
◽
Author(s):
Virginia Kaklamani
◽
Aditya Bardia
◽
Sharon Wilks
◽
Amy Weise
◽
Donald Richards
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Phase 1
◽
Growth Factor Receptor
◽
Final Analysis
◽
Phase 1 Study
◽
Estrogen Receptor Positive
◽
Epidermal Growth
Download Full-text
Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer
Cancer Science
◽
10.1111/cas.12897
◽
2016
◽
Vol 107
(4)
◽
pp. 491-498
◽
Cited By ~ 19
Author(s):
Mai Tomiguchi
◽
Yutaka Yamamoto
◽
Mutsuko Yamamoto‐Ibusuki
◽
Lisa Goto‐Yamaguchi
◽
Yoshitaka Fujiki
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Epidermal Growth Factor
◽
Fibroblast Growth Factor Receptor
◽
Growth Factor Receptor
◽
Fibroblast Growth
◽
Estrogen Receptor Positive
◽
Epidermal Growth
Download Full-text
The Dual Role of Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer
JAMA Oncology
◽
10.1001/jamaoncol.2015.0851
◽
2015
◽
Vol 1
(4)
◽
pp. 455
◽
Cited By ~ 1
Author(s):
Sibylle Loibl
Keyword(s):
Breast Cancer
◽
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Epidermal Growth Factor
◽
Primary Breast Cancer
◽
Growth Factor Receptor
◽
Tumor Infiltrating Lymphocytes
◽
Epidermal Growth
◽
Infiltrating Lymphocytes
Download Full-text
PALOMA-2: Neutropenia (NP) patterns in patients (Pts) with estrogen receptor−positive (ER+)/human epidermal growth factor receptor 2−negative (HER2–) first-line advanced breast cancer (ABC) receiving palbociclib + letrozole (P+L)
Annals of Oncology
◽
10.1093/annonc/mdx365.054
◽
2017
◽
Vol 28
◽
pp. v96
◽
Cited By ~ 3
Author(s):
V. Diéras
◽
N. Harbeck
◽
A.A. Joy
◽
K.A. Gelmon
◽
J. Ettl
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Epidermal Growth Factor
◽
Advanced Breast Cancer
◽
Growth Factor Receptor
◽
First Line
◽
Estrogen Receptor Positive
◽
Epidermal Growth
Download Full-text
Abstract P5-11-02: Dose-escalation study of SAR439859, an oral selective estrogen receptor degrader, in postmenopausal women with estrogen receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer
10.1158/1538-7445.sabcs19-p5-11-02
◽
2020
◽
Author(s):
Mario Campone
◽
Aditya Bardia
◽
Gary A Ulaner
◽
Sarat Chandarlapaty
◽
Alice Gosselin
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Epidermal Growth Factor Receptor
◽
Metastatic Breast Cancer
◽
Growth Factor
◽
Growth Factor Receptor
◽
Metastatic Breast
◽
Dose Escalation Study
◽
Estrogen Receptor Positive
◽
Epidermal Growth
Download Full-text
Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2
The Breast
◽
10.1016/j.breast.2021.07.017
◽
2021
◽
Author(s):
Karen Gelmon
◽
Janice M. Walshe
◽
Reshma Mahtani
◽
Anil A. Joy
◽
Meghan Karuturi
◽
...
Keyword(s):
Breast Cancer
◽
Estrogen Receptor
◽
Epidermal Growth Factor Receptor
◽
Growth Factor
◽
Growth Factor Receptor
◽
Efficacy And Safety
◽
Post Hoc Analysis
◽
Estrogen Receptor Positive
◽
Epidermal Growth
◽
Post Hoc
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close